Intrinsiqs

Is ImmunityBio, Inc. overvalued?

ImmunityBio, Inc. (IBRX) — key valuation metrics and fundamentals.

No verdict
Price
$6.02
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$6.40B
Dividend yield
0.0%
Return on equity
124.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IBRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.